Search Press releases

14 Oct 2024

UCB receives U.S. FDA approval for 320 mg single-injection device presentations of BIMZELX[®] (bimekizumab-bkzx)

Read More
11 Oct 2024

UCB showcases new data for gMG management at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and MGFA Scientific Session

Read More
10 Oct 2024

Transparency notification BlackRock, Inc.

Read More
9 Oct 2024

Transparency notification BlackRock, Inc.

Read More
3 Oct 2024

Transparency notification BlackRock, Inc.

Read More
1 Oct 2024

Transparency notification BlackRock, Inc.

Read More

Stay up-to-date on the latest news and information from UCB